icon-    folder.gif   Conference Reports for NATAP  
  21st Conference on Retroviruses and
Opportunistic Infections
Boston, MA March 3 - 6, 2014
Back grey_arrow_rt.gif
Dolutegravir in the French Named Patient Program* in Integrase HIV-2 Resistant Infected Patients
  Reported by Jules Levin
CROI 2014 March 3-6 Boston, mA
Diane Descamps,1-3 Gilles Peytavin,1,2,4 Florence Damond,1-3 Roland Tubiana,5 Pauline Campa,6 Marie-Aude Khuong-Josses,7 Claudine Duvivier,8 Marina Karmochkine,9 Tuna Lukiana,10 Sophie Matheron1, 2, 11 1IAME, UMR 1137, Univ Paris Diderot, Sorbonne Paris Cite, F-75018, Paris, France; 2 IAME, UMR 1137, INSERM, F-75018 Paris, France; 3AP-HP, Hopital Bichat-Claude Bernard, Laboratoire de Virologie, F-75018 Paris, France; 4AP-HP, Hopital Bichat,-Claude Bernard, Laboratoire de Pharmaco-Toxicologie, F-75018 Paris, France; 5AP-HP, Hopital Pitie-Salpetriere, Service des Maladies Infectieuses et Tropicales F-75013 Paris, France; 6AP-HP, Hopital Saint-Antoine, Service des Maladies Infectieuses et Tropicales F-75011 Paris, France; 7 Hopital Delafontaine, Service des Maladies Infectieuses et Tropicales, Saint-Denis, France; 8 AP-HP, Hopital Necker, Service des Maladies Infectieuses et tropicales, Centre d'Infectiologie Necker-Pasteur, F-75015, Paris, France; 9AP-HP, Hopital Europeen Georges Pompidou, Service d'Immunologie Clinique, F-75015, Paris, France; 10 ViiVhealthcare, F-78163, Marly le Roi, France; 11AP-HP, Hopital Bichat-Claude Bernard, Service des Maladies Infectieuses et Tropicales, F-75018 Paris, France.